Azstarys: The New Dual-Action ADHD Medication – A Comprehensive Guide
Azstarys – ADHD Medication, Side Effects, Reviews & Vyvanse Comparison Azstarys, approved by the FDA on March 2 2021 for use in patients 6 years and older with ADHD, is a relatively new treatment that combines immediate-release dexmethylphenidate with a pro-drug component for all-day symptom control. Why the excitement? In plain language, it’s designed to…